Negative results from the Alzheimer’s Prevention Initiative’s (API) Colombian study
So far, several trials of anti-amyloid monoclonal antibodies have failed to provide unequivocal evidence of reversing or even slowing cognitive decline in subjects with mild cognitive impairment (MCI) or mild Alzheimer’s dementia, despite marked...
Recent Comments